Research Paper Volume 13, Issue 12 pp 16696—16712

Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma

Survival analysis of EC patients belonging to different ICG expression subgroups. (A) Kaplan-Meier survival curves show OS of EC patients belonging to high or low IDO1 and TNFRSF14 expression groups. (B) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CD274 and TNFRSF14 expression groups. (C) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CTLA4 and TNFRSF14 expression groups. (D) Kaplan-Meier survival curves show OS of EC patients belonging to IDO1lowTNFRSF14high and IDO1lowTNFRSF14low expression groups. (E) Kaplan-Meier survival curves show OS of EC patients belonging to CD274lowTNFRSF14high and CD274lowTNFRSF14low expression groups. (F) Kaplan-Meier survival curves show OS of EC patients belonging to CTLA4lowTNFRSF14high and CTLA4lowTNFRSF14low expression groups. The abscissa represents survival time, and the ordinate represents overall survival.

Figure 9. Survival analysis of EC patients belonging to different ICG expression subgroups. (A) Kaplan-Meier survival curves show OS of EC patients belonging to high or low IDO1 and TNFRSF14 expression groups. (B) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CD274 and TNFRSF14 expression groups. (C) Kaplan-Meier survival curves show OS of EC patients belonging to high or low CTLA4 and TNFRSF14 expression groups. (D) Kaplan-Meier survival curves show OS of EC patients belonging to IDO1lowTNFRSF14high and IDO1lowTNFRSF14low expression groups. (E) Kaplan-Meier survival curves show OS of EC patients belonging to CD274lowTNFRSF14high and CD274lowTNFRSF14low expression groups. (F) Kaplan-Meier survival curves show OS of EC patients belonging to CTLA4lowTNFRSF14high and CTLA4lowTNFRSF14low expression groups. The abscissa represents survival time, and the ordinate represents overall survival.